Chitosan-carrageenan polyelectrolyte complex matrix as new protein/peptide drug carrier.
The oral route administration of protein and peptide drug has been limited by low bioavailability due to extensive hydrolysis and proteolytic enzymes activity in the gastrointestinal (GI) tract. Hence, chitosan-κ-carrageenan polyelectrolyte complex matrix that exhibit pH-dependent swelling character...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Final Year Project |
| 語言: | English |
| 出版: |
2009
|
| 主題: | |
| 在線閱讀: | http://hdl.handle.net/10356/16638 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|